Nivanex Dmx
Product Images NDC 75834-040

1 FDA label image from Nivagen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nivanex Dmx (NDC 75834-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (60 Tablet Bottle Label)

Principal Display Panel (60 Tablet Bottle Label)
Drug Facts panel for Nivanex DMX by Nivagen Pharmaceuticals, Inc. Lists active ingredients: Dextromethorphan HBr 15 mg, Guaifenesin 380 mg, Phenylephrine HCl 10 mg with their purposes as cough suppressant, expectorant, and nasal decongestant. Includes uses for symptom relief, warnings, directions by age group, other information on storage, and inactive ingredients. Also contains safety advice and customer service contact info.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.